Rendu Biotechnology Co., Ltd was founded in 2007. We focused on RNA molecular diagnosis. All products based on RNA isothermal amplification and real-time detection technology platform（named simultaneous amplification and testing (SAT)). SAT technology is RNA amplification by transcription mediated amplification and detection of the amplification products (RNA) by the fluorescent labeled probes. Our present assay products cover pathogens detection in reproductive health，respiratory tract infection，enterovirus and bloodborne infectious diseases. We also have fully automated instrument products, which are sample-in and result-out systems.
All our products are developed under EN ISO 13485 and 23 of them have been designed, developed and validated in accordance with the Directive 98/79/EC on in vitro diagnostic medical devices (CE-IVD).